@Article{信息:doi 10.2196 / / jmir。1576，作者=“Berry, Donna L和Halpenny, Barbara和Wolpin, Seth和Davison, B Joyce和Ellis, William J和Lober, William B和McReynolds, Justin和Wulff, Jennifer”，标题=“个人患者档案-前列腺(P3P)，一个基于web的决策支持系统的开发和评估，新诊断的男性局部前列腺癌”，期刊=“J Med Internet Res”，年=“2010”，月=“Dec”，日=“17”，卷=“12”，数=“4”，页=“e67”，关键词=“前列腺癌;决策;计算机辅助;背景:鉴于没有其他高发病率的局限性前列腺癌(LPC)有如此多的治疗方法，但与结果相关的确定性如此之少，许多男性面临着在临床医生的指导下承担治疗决策的一些责任。男人强烈地认为他们自己的个人特征和其他个人因素对决定是重要的和有影响的。临床研究人员尚未开发或全面调查干预措施，以促进个人因素和医疗因素的洞察力和优先级，这是一个人在准备治疗决定时所需要的。目的:本初步研究的目的是开发和评估基于网络的决策支持技术的可行性和可用性，即个人患者档案-前列腺(P3P)，用于新诊断为LPC的男性。方法:开发用例，然后开发基础结构和内容应用程序。该程序是在带有触摸屏显示器的个人台式电脑上提供的。 Participant responses to the query component of P3P determined the content of the multimedia educational and coaching intervention. The intervention was tailored to race, age, and personal factors reported as influencing the decision. Prepilot usability testing was conducted using a ``think aloud'' interview to identify navigation and content challenges. These issues were addressed prior to deployment in the clinic. A clinical pilot was conducted in an academic medical center where men sought consultation and treatment for LPC. Completion time, missing data, and acceptability were measured. Results: Prepilot testing included 4 men with a past diagnosis of LPC who had completed therapy. Technical navigation issues were documented along with confusing content language. A total of 30 additional men with a recent diagnosis of LPC completed the P3P program in clinic prior to consulting with a urologist regarding treatment options. In a mean time of 46 minutes (SD 13 minutes), participants completed the P3P query and intervention components. Of a possible 4560 items for 30 participants, 22 (0.5{\%}) were missing. Acceptability was reported as high overall. The sections of the intervention reported as most useful were the statistics graphs, priority information topics, and annotated external website links. Conclusions: The P3P intervention is a feasible and usable program to facilitate treatment decision making by men with newly diagnosed LPC. Testing in a multisite randomized trial with a diverse sample is warranted. ", issn="1438-8871", doi="10.2196/jmir.1576", url="//www.mybigtv.com/2010/4/e67/", url="https://doi.org/10.2196/jmir.1576", url="http://www.ncbi.nlm.nih.gov/pubmed/21169159" }